Takeda Pharma, Millennium commence TRINOVA-1 Phase III cancer trial
TRINOVA-1 is a global multicenter, randomized, double-blind trial of paclitaxel plus AMG 386 or placebo in women with recurrent ovarian cancer. Discovered by Amgen, the cancer agent targets
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.